Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor
- Status
- COMPLETED
- Phase
- N/A
Ilaris® Effects in Schnitzler Syndrome (ILESCH)
- Status
- COMPLETED
- Phase
- PHASE2
A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
- Status
- TERMINATED
- Phase
- NA
A Study of BYL719 in Adult Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- Status
- COMPLETED
- Phase
- PHASE2
BKM120 in Metastatic Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
- Status
- TERMINATED
- Phase
- PHASE2
Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Indacaterol 150 µg Versus Formoterol
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents
- Status
- COMPLETED
- Phase
- PHASE3
Changes in Pituitary Iron and Volume With Deferasirox
- Status
- COMPLETED
- Phase
- N/A
GSK1120212 Rollover Study
- Status
- TERMINATED
- Phase
- PHASE2
Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
- Status
- COMPLETED
- Phase
- N/A
Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
- Status
- COMPLETED
- Phase
- PHASE3